{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:05:46Z","timestamp":1779318346115,"version":"3.51.4"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"S4","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:p>Diese Leitlinie repr\u00e4sentiert die Empfehlungen der \u00d6sterreichischen Diabetes Gesellschaft (\u00d6DG) zur Nutzung von Diabetes-Technologie (kontinuierliche Glukosemesssysteme [CGM], Insulinpumpentherapie, Automated-Insulin-Delivery-Systeme [AID], \u201econnected insulin pens\u201c, Diabetes-Apps) und den Zugang zu diesen technologischen Innovationen f\u00fcr Menschen mit Diabetes mellitus. Die Leitlinie wurde basierend auf aktueller wissenschaftlicher Evidenz erstellt.<\/jats:p>","DOI":"10.1007\/s00508-025-02630-7","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:13:21Z","timestamp":1779315201000},"page":"161-170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diabetestechnologie (Update 2026)","Diabetes technology (Update 2026)"],"prefix":"10.1007","volume":"138","author":[{"given":"Ingrid","family":"Sch\u00fctz-Fuhrmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Rami-Merhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine E.","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Fr\u00f6hlich-Reiterer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Tauschmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia K.","family":"Mader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Resl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Kautzky-Willer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Winhofer-St\u00f6ckl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Wascher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Harreiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Stechemesser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Zlamal-Fortunat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raimund","family":"Weitgasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"issue":"7","key":"2630_CR1","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1464-5491.2008.02486.x","volume":"25","author":"JC Pickup","year":"2008","unstructured":"Pickup\u00a0JC, Sutton\u00a0AJ. Severe hypoglycaemia and glycaemic control in type\u00a01 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med. 2008;25(7):765\u201374.","journal-title":"Diabet Med"},{"issue":"5","key":"2630_CR2","doi-asserted-by":"publisher","first-page":"336","DOI":"10.7326\/0003-4819-157-5-201209040-00508","volume":"157","author":"HC Yeh","year":"2012","unstructured":"Yeh\u00a0HC, Brown\u00a0TT, Maruthur\u00a0N, Ranasinghe\u00a0P, Berger\u00a0Z, Suh\u00a0YD, et\u00a0al. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a\u00a0systematic review and meta-analysis. Ann Intern Med. 2012;157(5):336\u201347.","journal-title":"Ann Intern Med"},{"issue":"6","key":"2630_CR3","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00125-008-0974-3","volume":"51","author":"K Jeitler","year":"2008","unstructured":"Jeitler\u00a0K, Horvath\u00a0K, Berghold\u00a0A, Gratzer\u00a0TW, Neeser\u00a0K, Pieber\u00a0TR, et\u00a0al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia. 2008;51(6):941\u201351.","journal-title":"Diabetologia"},{"issue":"3","key":"2630_CR4","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1210\/jc.2008-1415","volume":"94","author":"MM Fatourechi","year":"2009","unstructured":"Fatourechi\u00a0MM, Kudva\u00a0YC, Murad\u00a0MH, Elamin\u00a0MB, Tabini\u00a0CC, Montori\u00a0VM. Clinical review: hypoglycemia with intensive insulin therapy: a\u00a0systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J\u00a0Clin Endocrinol Metab. 2009;94(3):729\u201340.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2630_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1399-5448.2008.00440.x","volume":"10","author":"E Pa\u0144kowska","year":"2009","unstructured":"Pa\u0144kowska\u00a0E, B\u0142azik\u00a0M, Dziechciarz\u00a0P, Szypowska\u00a0A, Szajewska\u00a0H. Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type\u00a01 diabetes: a\u00a0systematic review and meta-analysis of randomized control trials. Pediatr Diabetes. 2009;10(1):52\u20138.","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"2630_CR6","first-page":"Cd008101","volume":"1","author":"M Langendam","year":"2012","unstructured":"Langendam\u00a0M, Luijf\u00a0YM, Hooft\u00a0L, Devries\u00a0JH, Mudde\u00a0AH, Scholten\u00a0RJ. Continuous glucose monitoring systems for type\u00a01 diabetes mellitus. Cochrane Database Syst Rev. 2012;1(1):Cd8101.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2630_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1002853","volume":"363","author":"RM Bergenstal","year":"2010","unstructured":"Bergenstal\u00a0RM, Tamborlane\u00a0WV, Ahmann\u00a0A, Buse\u00a0JB, Dailey\u00a0G, Davis\u00a0SN, et\u00a0al. Effectiveness of sensor-augmented insulin-pump therapy in type\u00a01 diabetes. N\u00a0Engl J Med. 2010;363(4):311\u201320.","journal-title":"N Engl J Med"},{"key":"2630_CR8","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.2147\/IJGM.S418520","volume":"16","author":"L Huang","year":"2023","unstructured":"Huang\u00a0L, Pan\u00a0Y, Zhou\u00a0K, Liu\u00a0H, Zhong\u00a0S. Correlation between glycemic variability and diabetic complications: a\u00a0narrative review. Int J Gen Med. 2023;16:3083\u201394.","journal-title":"Int J Gen Med"},{"issue":"8","key":"2630_CR9","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino\u00a0T, Danne\u00a0T, Bergenstal\u00a0RM, Amiel\u00a0SA, Beck\u00a0R, Biester\u00a0T, et\u00a0al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593\u2013603.","journal-title":"Diabetes Care"},{"issue":"12","key":"2630_CR10","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2337\/dc17-1600","volume":"40","author":"T Danne","year":"2017","unstructured":"Danne\u00a0T, Nimri\u00a0R, Battelino\u00a0T, Bergenstal\u00a0RM, Close\u00a0KL, DeVries\u00a0JH, et\u00a0al. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017;40(12):1631\u201340.","journal-title":"Diabetes Care"},{"issue":"12","key":"2630_CR11","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1007\/s00125-021-05568-3","volume":"64","author":"RIG Holt","year":"2021","unstructured":"Holt\u00a0RIG, DeVries\u00a0JH, Hess-Fischl\u00a0A, Hirsch\u00a0IB, Kirkman\u00a0MS, Klupa\u00a0T, et\u00a0al. The management of type\u00a01 diabetes in adults. A\u00a0consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2021;64(12):2609\u201352.","journal-title":"Diabetologia"},{"issue":"3","key":"2630_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1089\/dia.2023.0565","volume":"26","author":"TC Dunn","year":"2024","unstructured":"Dunn\u00a0TC, Ajjan\u00a0RA, Bergenstal\u00a0RM, Xu\u00a0Y. Is it time to move beyond TIR to TITR? Real-world data from over 20,000 users of continuous glucose monitoring in patients with type\u00a01 and type\u00a02 diabetes. Diabetes Technol Ther. 2024;26(3):203\u201310.","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"2630_CR13","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/clinchem\/hvac210","volume":"69","author":"M Fang","year":"2023","unstructured":"Fang\u00a0M, Wang\u00a0D, Rooney\u00a0MR, Echouffo-Tcheugui\u00a0JB, Coresh\u00a0J, Aurora\u00a0RN, et\u00a0al. Performance of the glucose management indicator (GMI) in type\u00a02 diabetes. Clin Chem. 2023;69(4):422\u20138.","journal-title":"Clin Chem"},{"issue":"9","key":"2630_CR14","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1089\/dia.2019.0405","volume":"22","author":"E Angellotti","year":"2020","unstructured":"Angellotti\u00a0E, Muppavarapu\u00a0S, Siegel\u00a0RD, Pittas\u00a0AG. The calculation of the glucose management indicator is influenced by the continuous glucose monitoring system and patient race. Diabetes Technol Ther. 2020;22(9):651\u20137.","journal-title":"Diabetes Technol Ther"},{"key":"2630_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/bios12050288","author":"P Fellinger","year":"2022","unstructured":"Fellinger\u00a0P, Rodewald\u00a0K, Ferch\u00a0M, Itariu\u00a0B, Kautzky-Willer\u00a0A, Winhofer\u00a0Y. HbA1c and glucose management indicator discordance associated with obesity and type\u00a02 diabetes in intermittent scanning glucose monitoring system. Biosensors. 2022; https:\/\/doi.org\/10.3390\/bios12050288.","journal-title":"Biosensors"},{"issue":"2","key":"2630_CR16","doi-asserted-by":"publisher","first-page":"262","DOI":"10.2337\/dc10-1732","volume":"34","author":"WH Polonsky","year":"2011","unstructured":"Polonsky\u00a0WH, Fisher\u00a0L, Schikman\u00a0CH, Hinnen\u00a0DA, Parkin\u00a0CG, Jelsovsky\u00a0Z, et\u00a0al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type\u00a02 diabetes: results from the structured testing program study. Diabetes Care. 2011;34(2):262\u20137.","journal-title":"Diabetes Care"},{"issue":"1","key":"2630_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/1932296817719290","volume":"12","author":"E Mannucci","year":"2018","unstructured":"Mannucci\u00a0E, Antenore\u00a0A, Giorgino\u00a0F, Scavini\u00a0M. Effects of structured versus unstructured self-monitoring of blood glucose on glucose control in patients with non-insulin-treated type\u00a02 diabetes: a\u00a0meta-analysis of randomized controlled trials. J\u00a0Diabetes Sci Technol. 2018;12(1):183\u20139.","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"2630_CR18","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s12325-023-02478-1","volume":"40","author":"I Cranston","year":"2023","unstructured":"Cranston\u00a0I, Jamdade\u00a0V, Liao\u00a0B, Newson\u00a0RS. Clinical, economic, and patient-reported benefits of connected insulin pen systems: a\u00a0systematic literature review. Adv Ther. 2023;40(5):2015\u201337.","journal-title":"Adv Ther"},{"issue":"6","key":"2630_CR19","doi-asserted-by":"publisher","first-page":"995","DOI":"10.2337\/dc23-2176","volume":"47","author":"TPA Danne","year":"2024","unstructured":"Danne\u00a0TPA, Joubert\u00a0M, Hartvig\u00a0NV, Kaas\u00a0A, Knudsen\u00a0NN, Mader\u00a0JK. Association between treatment adherence and continuous glucose monitoring outcomes in people with diabetes using smart insulin pens in a\u00a0real-world setting. Diabetes Care. 2024;47(6):995\u20131003.","journal-title":"Diabetes Care"},{"issue":"6","key":"2630_CR20","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1159\/000543156","volume":"97","author":"M Tauschmann","year":"2024","unstructured":"Tauschmann\u00a0M, Cardona-Hernandez\u00a0R, DeSalvo\u00a0DJ, Hood\u00a0K, Laptev\u00a0DN, Lindholm Olinder\u00a0A, et\u00a0al. International society for pediatric and adolescent diabetes clinical practice consensus guidelines 2024 diabetes technologies: glucose monitoring. Horm Res Paediatr. 2024;97(6):615\u201335.","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"2630_CR21","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1159\/000543034","volume":"97","author":"T Biester","year":"2024","unstructured":"Biester\u00a0T, Berget\u00a0C, Boughton\u00a0C, Cudizio\u00a0L, Ekhlaspour\u00a0L, Hilliard\u00a0ME, et\u00a0al. International society for pediatric and adolescent diabetes clinical practice consensus guidelines 2024: diabetes technologies\u2014insulin delivery. Horm Res Paediatr. 2024;97(6):636\u201362.","journal-title":"Horm Res Paediatr"},{"issue":"3","key":"2630_CR22","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1056\/NEJMoa1303576","volume":"369","author":"RM Bergenstal","year":"2013","unstructured":"Bergenstal\u00a0RM, Klonoff\u00a0DC, Garg\u00a0SK, Bode\u00a0BW, Meredith\u00a0M, Slover\u00a0RH, et\u00a0al. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N\u00a0Engl J Med. 2013;369(3):224\u201332.","journal-title":"N Engl J Med"},{"issue":"11","key":"2630_CR23","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.2337\/dc19-0345","volume":"42","author":"L van den Boom","year":"2019","unstructured":"van den Boom\u00a0L, Karges\u00a0B, Auzanneau\u00a0M, Rami-Merhar\u00a0B, Lilienthal\u00a0E, von Sengbusch\u00a0S, et\u00a0al. Temporal trends and contemporary use of insulin pump therapy and glucose monitoring among children, adolescents, and adults with type\u00a01 diabetes between 1995 and 2017. Diabetes Care. 2019;42(11):2050\u20136.","journal-title":"Diabetes Care"},{"issue":"14","key":"2630_CR24","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1001\/jama.2017.13994","volume":"318","author":"B Karges","year":"2017","unstructured":"Karges\u00a0B, Schwandt\u00a0A, Heidtmann\u00a0B, Kordonouri\u00a0O, Binder\u00a0E, Schierloh\u00a0U, et\u00a0al. Association of insulin pump therapy vs insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with type\u00a01 diabetes. JAMA. 2017;318(14):1358\u201366.","journal-title":"JAMA"},{"issue":"12","key":"2630_CR25","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1001\/jama.2013.277818","volume":"310","author":"TT Ly","year":"2013","unstructured":"Ly\u00a0TT, Nicholas\u00a0JA, Retterath\u00a0A, Lim\u00a0EM, Davis\u00a0EA, Jones\u00a0TW. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type\u00a01 diabetes: a\u00a0randomized clinical trial. JAMA. 2013;310(12):1240\u20137.","journal-title":"JAMA"},{"issue":"6","key":"2630_CR26","doi-asserted-by":"publisher","first-page":"764","DOI":"10.2337\/dc16-2584","volume":"40","author":"T Battelino","year":"2017","unstructured":"Battelino\u00a0T, Nimri\u00a0R, Dovc\u00a0K, Phillip\u00a0M, Bratina\u00a0N. Prevention of hypoglycemia with predictive low glucose insulin suspension in children with type\u00a01 diabetes: a\u00a0randomized controlled trial. Diabetes Care. 2017;40(6):764\u201370.","journal-title":"Diabetes Care"},{"issue":"1","key":"2630_CR27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13098-023-01144-4","volume":"15","author":"A Godoi","year":"2023","unstructured":"Godoi\u00a0A, Reis Marques\u00a0I, Padr\u00e3o\u00a0EMH, Mahesh\u00a0A, Hespanhol\u00a0LC, Riceto Loyola J\u00fanior\u00a0JE, et\u00a0al. Glucose control and psychosocial outcomes with use of automated insulin delivery for 12 to 96\u00a0weeks in type\u00a01 diabetes: a\u00a0meta-analysis of randomised controlled trials. Diabetol Metab Syndr. 2023;15(1):190.","journal-title":"Diabetol Metab Syndr"},{"issue":"S3","key":"2630_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1089\/dia.2023.0442","volume":"26","author":"EG Considine","year":"2024","unstructured":"Considine\u00a0EG, Sherr\u00a0JL. Real-world evidence of automated insulin delivery system use. Diabetes Technol Ther. 2024;26(S3):53\u201365.","journal-title":"Diabetes Technol Ther"},{"key":"2630_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s00112-021-01239-0","author":"T Biester","year":"2021","unstructured":"Biester\u00a0T, Dovc\u00a0K, Chobot\u00a0A, Tauschmann\u00a0M, Kapellen\u00a0T. Individualization of diabetes treatment by automated insulin delivery. Monatsschr Kinderheilkd. 2021; https:\/\/doi.org\/10.1007\/s00112-021-01239-0.","journal-title":"Monatsschr Kinderheilkd"},{"issue":"9","key":"2630_CR30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00508-024-02400-x","volume":"136","author":"AT Kietaibl","year":"2024","unstructured":"Kietaibl\u00a0AT, Sch\u00fctz-Fuhrmann\u00a0I, Bozkurt\u00a0L, Fr\u00fchwald\u00a0L, Rami-Merhar\u00a0B, Fr\u00f6hlich-Reiterer\u00a0E, et\u00a0al. Position paper: open-source technology in the treatment of people living with diabetes mellitus-an Austrian perspective : technology committee of the Austrian diabetes association. Wien Klin Wochenschr. 2024;136(9):467\u201377.","journal-title":"Wien Klin Wochenschr"},{"issue":"10110","key":"2630_CR31","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/S0140-6736(17)32400-5","volume":"390","author":"DS Feig","year":"2017","unstructured":"Feig\u00a0DS, Donovan\u00a0LE, Corcoy\u00a0R, Murphy\u00a0KE, Amiel\u00a0SA, Hunt\u00a0KF, et\u00a0al. Continuous glucose monitoring in pregnant women with type\u00a01 diabetes (CONCEPTT): a\u00a0multicentre international randomised controlled trial. Lancet. 2017;390(10110):2347\u201359.","journal-title":"Lancet"},{"issue":"S1","key":"2630_CR32","first-page":"S8","volume":"23","author":"JM Yamamoto","year":"2021","unstructured":"Yamamoto\u00a0JM, Murphy\u00a0HR. Benefits of real-time continuous glucose monitoring in pregnancy. Diabetes Technol Ther. 2021;23(S1):S8\u2013s14.","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"2630_CR33","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.2337\/dc18-1437","volume":"41","author":"DS Feig","year":"2018","unstructured":"Feig\u00a0DS, Corcoy\u00a0R, Donovan\u00a0LE, Murphy\u00a0KE, Barrett\u00a0JFR, Sanchez\u00a0JJ, et\u00a0al. Pumps or multiple daily injections in pregnancy involving type\u00a01 diabetes: a\u00a0prespecified analysis of the CONCEPTT randomized trial. Diabetes Care. 2018;41(12):2471\u20139.","journal-title":"Diabetes Care"},{"issue":"17","key":"2630_CR34","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1056\/NEJMoa2303911","volume":"389","author":"TTM Lee","year":"2023","unstructured":"Lee\u00a0TTM, Collett\u00a0C, Bergford\u00a0S, Hartnell\u00a0S, Scott\u00a0EM, Lindsay\u00a0RS, et\u00a0al. Automated insulin delivery in women with pregnancy complicated by type\u00a01 diabetes. N\u00a0Engl J Med. 2023;389(17):1566\u201378.","journal-title":"N Engl J Med"},{"issue":"6","key":"2630_CR35","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S2213-8587(24)00089-5","volume":"12","author":"K Benhalima","year":"2024","unstructured":"Benhalima\u00a0K, Beunen\u00a0K, Van Wilder\u00a0N, Ballaux\u00a0D, Vanhaverbeke\u00a0G, Taes\u00a0Y, et\u00a0al. Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type\u00a01 diabetes (CRISTAL): a\u00a0parallel-group, open-label, randomised controlled trial. Lancet Diabetes Endocrinol. 2024;12(6):390\u2013403.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"2630_CR36","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.1210\/jc.2013-4332","volume":"99","author":"F Yu","year":"2014","unstructured":"Yu\u00a0F, Lv\u00a0L, Liang\u00a0Z, Wang\u00a0Y, Wen\u00a0J, Lin\u00a0X, et\u00a0al. Continuous glucose monitoring effects on maternal glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus: a\u00a0prospective cohort study. J\u00a0Clin Endocrinol Metab. 2014;99(12):4674\u201382.","journal-title":"J Clin Endocrinol Metab"},{"key":"2630_CR37","doi-asserted-by":"publisher","first-page":"19920","DOI":"10.1038\/srep19920","volume":"6","author":"Q Wei","year":"2016","unstructured":"Wei\u00a0Q, Sun\u00a0Z, Yang\u00a0Y, Yu\u00a0H, Ding\u00a0H, Wang\u00a0S. Effect of a\u00a0CGMS and SMBG on maternal and neonatal outcomes in gestational diabetes mellitus: a\u00a0randomized controlled trial. Sci Rep. 2016;6:19920.","journal-title":"Sci Rep"},{"issue":"9","key":"2630_CR38","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1055\/s-0039-1678733","volume":"36","author":"AS Lane","year":"2019","unstructured":"Lane\u00a0AS, Mlynarczyk\u00a0MA, de Veciana\u00a0M, Green\u00a0LM, Baraki\u00a0DI, Abuhamad\u00a0AZ. Real-time continuous glucose monitoring in gestational diabetes: a\u00a0randomized controlled trial. Am J Perinatol. 2019;36(9):891\u20137.","journal-title":"Am J Perinatol"},{"key":"2630_CR39","doi-asserted-by":"publisher","first-page":"110678","DOI":"10.1016\/j.diabres.2023.110678","volume":"199","author":"P Michou","year":"2023","unstructured":"Michou\u00a0P, Gkiourtzis\u00a0N, Christoforidis\u00a0A, Kotanidou\u00a0EP, Galli-Tsinopoulou\u00a0A. The efficacy of automated insulin delivery systems in children and adolescents with type\u00a01 diabetes mellitus: a\u00a0systematic review and meta-analysis of randomized controlled trials. Diabetes Res Clin Pract. 2023;199:110678.","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"2630_CR40","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.2337\/dc23-0504","volume":"46","author":"B Zeng","year":"2023","unstructured":"Zeng\u00a0B, Gao\u00a0L, Yang\u00a0Q, Jia\u00a0H, Sun\u00a0F. Automated insulin delivery systems in children and adolescents with type\u00a01 diabetes: a\u00a0systematic review and meta-analysis of outpatient randomized controlled trials. Diabetes Care. 2023;46(12):2300\u20137.","journal-title":"Diabetes Care"},{"issue":"10","key":"2630_CR41","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s00125-024-06218-0","volume":"67","author":"MJ Schoelwer","year":"2024","unstructured":"Schoelwer\u00a0MJ, DeBoer\u00a0MD, Breton\u00a0MD. Use of diabetes technology in children. Diabetologia. 2024;67(10):2075\u201384.","journal-title":"Diabetologia"},{"issue":"8","key":"2630_CR42","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1111\/pedi.13445","volume":"23","author":"E Fr\u00f6hlich-Reiterer","year":"2022","unstructured":"Fr\u00f6hlich-Reiterer\u00a0E, Elbarbary\u00a0NS, Simmons\u00a0K, Buckingham\u00a0B, Humayun\u00a0KN, Johannsen\u00a0J, et\u00a0al. ISPAD clinical practice consensus guidelines 2022: other complications and associated conditions in children and adolescents with type\u00a01 diabetes. Pediatr Diabetes. 2022;23(8):1451\u201367.","journal-title":"Pediatr Diabetes"},{"issue":"3","key":"2630_CR43","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/pedi.12085","volume":"15","author":"U Samuelsson","year":"2014","unstructured":"Samuelsson\u00a0U, Steineck\u00a0I, Gubbjornsdottir\u00a0S. A\u00a0high mean-HbA1c value 3\u201315\u00a0months after diagnosis of type\u00a01 diabetes in childhood is related to metabolic control, macroalbuminuria, and retinopathy in early adulthood\u2014a pilot study using two nation-wide population based quality registries. Pediatr Diabetes. 2014;15(3):229\u201335.","journal-title":"Pediatr Diabetes"},{"issue":"5","key":"2630_CR44","first-page":"494","volume":"20","author":"V Mazarello Paes","year":"2019","unstructured":"Mazarello Paes\u00a0V, Barrett\u00a0JK, Taylor-Robinson\u00a0DC, Chesters\u00a0H, Charalampopoulos\u00a0D, Dunger\u00a0DB, et\u00a0al. Effect of early glycemic control on HbA1c tracking and development of vascular complications after 5\u00a0years of childhood onset type\u00a01 diabetes: systematic review and meta-analysis. Pediatr Diabetes. 2019;20(5):494\u2013509.","journal-title":"Pediatr Diabetes"},{"key":"2630_CR45","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-0360","author":"J Ware","year":"2024","unstructured":"Ware\u00a0J, Boughton\u00a0CK, Allen\u00a0JM, Wilinska\u00a0ME, Hartnell\u00a0S, Thankamony\u00a0A, et\u00a0al. Effect of 48\u00a0months of closed-loop insulin delivery on residual C\u2011peptide secretion and glycemic control in newly diagnosed youth with type\u00a01 diabetes: a\u00a0randomized trial. Diabetes Care. 2024; https:\/\/doi.org\/10.2337\/dc24-0360.","journal-title":"Diabetes Care"},{"issue":"1","key":"2630_CR46","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13098-021-00654-3","volume":"13","author":"M Krakauer","year":"2021","unstructured":"Krakauer\u00a0M, Botero\u00a0JF, Lavalle-Gonz\u00e1lez\u00a0FJ, Proietti\u00a0A, Barbieri\u00a0DE. A\u00a0review of flash glucose monitoring in type\u00a02 diabetes. Diabetol Metab Syndr. 2021;13(1):42.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"2630_CR47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13300-016-0223-6","volume":"8","author":"T Haak","year":"2017","unstructured":"Haak\u00a0T, Hanaire\u00a0H, Ajjan\u00a0R, Hermanns\u00a0N, Riveline\u00a0JP, Rayman\u00a0G. Flash glucose-sensing technology as a\u00a0replacement for blood glucose monitoring for the management of insulin-treated type\u00a02 diabetes: a\u00a0multicenter, open-label randomized controlled trial. Diabetes Ther. 2017;8(1):55\u201373.","journal-title":"Diabetes Ther"},{"issue":"6","key":"2630_CR48","doi-asserted-by":"publisher","first-page":"365","DOI":"10.7326\/M16-2855","volume":"167","author":"RW Beck","year":"2017","unstructured":"Beck\u00a0RW, Riddlesworth\u00a0TD, Ruedy\u00a0K, Ahmann\u00a0A, Haller\u00a0S, Kruger\u00a0D, et\u00a0al. Continuous glucose monitoring versus usual care in patients with type\u00a02 diabetes receiving multiple daily insulin injections: a\u00a0randomized trial. Ann Intern Med. 2017;167(6):365\u201374.","journal-title":"Ann Intern Med"},{"issue":"22","key":"2630_CR49","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1001\/jama.2021.7444","volume":"325","author":"T Martens","year":"2021","unstructured":"Martens\u00a0T, Beck\u00a0RW, Bailey\u00a0R, Ruedy\u00a0KJ, Calhoun\u00a0P, Peters\u00a0AL, et\u00a0al. Effect of continuous glucose monitoring on glycemic control in patients with type\u00a02 diabetes treated with basal insulin: a\u00a0randomized clinical trial. JAMA. 2021;325(22):2262\u201372.","journal-title":"JAMA"},{"issue":"1","key":"2630_CR50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2337\/dc11-1438","volume":"35","author":"RA Vigersky","year":"2012","unstructured":"Vigersky\u00a0RA, Fonda\u00a0SJ, Chellappa\u00a0M, Walker\u00a0MS, Ehrhardt\u00a0NM. Short- and long-term effects of real-time continuous glucose monitoring in patients with type\u00a02 diabetes. Diabetes Care. 2012;35(1):32\u20138.","journal-title":"Diabetes Care"},{"issue":"4","key":"2630_CR51","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/jdi.12807","volume":"9","author":"PJ Taylor","year":"2018","unstructured":"Taylor\u00a0PJ, Thompson\u00a0CH, Brinkworth\u00a0GD. Effectiveness and acceptability of continuous glucose monitoring for type\u00a02 diabetes management: a\u00a0narrative review. J\u00a0Diabetes Investig. 2018;9(4):713\u201325.","journal-title":"J Diabetes Investig"},{"issue":"5","key":"2630_CR52","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2337\/dc16-2201","volume":"40","author":"JC Pickup","year":"2017","unstructured":"Pickup\u00a0JC, Reznik\u00a0Y, Sutton\u00a0AJ. Glycemic control during continuous subcutaneous insulin infusion versus multiple daily insulin injections in type\u00a02 diabetes: individual patient data meta-analysis and meta-regression of randomized controlled trials. Diabetes Care. 2017;40(5):715\u201322.","journal-title":"Diabetes Care"},{"issue":"18","key":"2630_CR53","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1056\/NEJMoa2415948","volume":"392","author":"YC Kudva","year":"2025","unstructured":"Kudva\u00a0YC, Raghinaru\u00a0D, Lum\u00a0JW, Graham\u00a0TE, Liljenquist\u00a0D, Spanakis\u00a0EK, et\u00a0al. A\u00a0randomized trial of automated insulin delivery in type\u00a02 diabetes. N\u00a0Engl J Med. 2025;392(18):1801\u201312.","journal-title":"N Engl J Med"},{"issue":"5","key":"2630_CR54","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1097\/SLA.0000000000006549","volume":"281","author":"G Krutkyte","year":"2025","unstructured":"Krutkyte\u00a0G, Goerg\u00a0AMC, Grob\u00a0CA, Piazza\u00a0CD, Rolfes\u00a0ED, Gloor\u00a0B, et\u00a0al. Perioperative fully closed-loop versus usual care glucose management in adults undergoing major abdominal surgery: a\u00a0two-centre randomized controlled trial. Ann Surg. 2025;281(5):732\u201340.","journal-title":"Ann Surg"},{"issue":"3","key":"2630_CR55","doi-asserted-by":"publisher","first-page":"e0193569","DOI":"10.1371\/journal.pone.0193569","volume":"13","author":"JM Werzowa","year":"2018","unstructured":"Werzowa\u00a0JM, S\u00e4emann\u00a0MD, Mohl\u00a0A, Bergmann\u00a0M, Kaltenecker\u00a0CC, Brozek\u00a0W, et\u00a0al. A\u00a0randomized controlled trial-based algorithm for insulin-pump therapy in hyperglycemic patients early after kidney transplantation. PLoS ONE. 2018;13(3):e193569.","journal-title":"PLoS ONE"},{"issue":"11","key":"2630_CR56","first-page":"753","volume":"23","author":"BE Marks","year":"2021","unstructured":"Marks\u00a0BE, Kilberg\u00a0MJ, Aliaj\u00a0E, Fredkin\u00a0K, Hudson\u00a0J, Riva\u00a0D, et\u00a0al. Perceptions of diabetes technology use in cystic fibrosis-related diabetes management. Diabetes Technol Ther. 2021;23(11):753\u20139.","journal-title":"Diabetes Technol Ther"},{"issue":"11","key":"2630_CR57","first-page":"Cd013755","volume":"11","author":"A Toner","year":"2021","unstructured":"Toner\u00a0A, McCloy\u00a0A, Dyce\u00a0P, Nazareth\u00a0D, Frost\u00a0F. Continuous glucose monitoring systems for monitoring cystic fibrosis-related diabetes. Cochrane Database Syst Rev. 2021;11(11):Cd13755.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2630_CR58","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.jcf.2019.08.025","volume":"18","author":"CL Chan","year":"2019","unstructured":"Chan\u00a0CL, Ode\u00a0KL, Granados\u00a0A, Moheet\u00a0A, Moran\u00a0A, Hameed\u00a0S. Continuous glucose monitoring in cystic fibrosis\u2014a practical guide. J\u00a0Cyst Fibros. 2019;18(2):S25\u2013s31.","journal-title":"J Cyst Fibros"},{"issue":"3","key":"2630_CR59","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/pedi.13180","volume":"22","author":"AC Sarteau","year":"2021","unstructured":"Sarteau\u00a0AC, Souris\u00a0KJ, Wang\u00a0J, Ramadan\u00a0AA, Addala\u00a0A, Bowlby\u00a0D, et\u00a0al. Changes to care delivery at nine international pediatric diabetes clinics in response to the COVID-19 global pandemic. Pediatr Diabetes. 2021;22(3):463\u20138.","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"2630_CR60","doi-asserted-by":"publisher","first-page":"e14433","DOI":"10.1111\/dme.14433","volume":"38","author":"EG Wilmot","year":"2021","unstructured":"Wilmot\u00a0EG, Lumb\u00a0A, Hammond\u00a0P, Murphy\u00a0HR, Scott\u00a0E, Gibb\u00a0FW, et\u00a0al. Time in range: a\u00a0best practice guide for UK diabetes healthcare professionals in the context of the COVID-19 global pandemic. Diabet Med. 2021;38(1):e14433.","journal-title":"Diabet Med"},{"issue":"2","key":"2630_CR61","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s41969-025-00266-6","volume":"18","author":"M Resl","year":"2025","unstructured":"Resl\u00a0M, K\u00f6hler\u00a0G, Treiber\u00a0G, Mallinger-Taferner\u00a0B, Sch\u00fctz Fuhrmann\u00a0I, Stechemesser\u00a0L, et\u00a0al. Positionspapier \u2013 Telemedizin in der Behandlung von Menschen mit Diabetes mellitus. J\u00a0Endokrinol Diabetol Stoffw. 2025;18(2):44\u20137.","journal-title":"J. Endokrinol. Diabetol. Stoffw."},{"issue":"1","key":"2630_CR62","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.2337\/dc21-S007","volume":"44","author":"American Diabetes Association","year":"2021","unstructured":"American Diabetes Association. 7. diabetes technology. Diabetes Care. 2021;44(1):S85\u2013S99.","journal-title":"Diabetes Care"},{"issue":"10","key":"2630_CR63","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1016\/j.pec.2019.04.021","volume":"102","author":"D Bergis","year":"2019","unstructured":"Bergis\u00a0D, Ehrmann\u00a0D, Albrecht\u00a0C, Haak\u00a0T, Kulzer\u00a0B, Hermanns\u00a0N. Comparison of the efficacy of an education program for people with diabetes and insulin pump treatment (INPUT) in a\u00a0randomized controlled trial setting and the effectiveness in a\u00a0routine care setting: results of a\u00a0comparative effectiveness study. Patient Educ Couns. 2019;102(10):1868\u201374.","journal-title":"Patient Educ Couns"},{"issue":"2","key":"2630_CR64","doi-asserted-by":"publisher","first-page":"e14467","DOI":"10.1111\/dme.14467","volume":"38","author":"S Schl\u00fcter","year":"2021","unstructured":"Schl\u00fcter\u00a0S, Freckmann\u00a0G, Heinemann\u00a0L, Wintergerst\u00a0P, Lange\u00a0K. Evaluation of the SPECTRUM training programme for real-time continuous glucose monitoring: a\u00a0real-world multicentre prospective study in 120 adults with type\u00a01 diabetes. Diabet Med. 2021;38(2):e14467.","journal-title":"Diabet Med"},{"key":"2630_CR65","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.2337\/dc20-1690","volume":"44","author":"R Roussel","year":"2021","unstructured":"Roussel\u00a0R, Riveline\u00a0J\u2011P, Vicaut\u00a0E, et\u00a0al. Important drop in rate of acute diabetes complications in people with type\u00a01 or type\u00a02 diabetes after initiation of flash glucose monitoring in France: the RELIEF study. Diabetes Care. 2021;44:1368\u201376.","journal-title":"Diabetes Care"},{"key":"2630_CR66","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1089\/dia.2022.0085","volume":"24","author":"J-P Riveline","year":"2022","unstructured":"Riveline\u00a0J\u2011P, Roussel\u00a0R, Vicaut\u00a0E, et\u00a0al. Reduced rate of acute diabetes events with flash glucose monitoring is sustained for 2\u00a0years after initiation: extended outcomes from the RELIEF study. Diabetes Technol Ther. 2022;24:611\u20138.","journal-title":"Diabetes Technol Ther"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-025-02630-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-025-02630-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-025-02630-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:13:23Z","timestamp":1779315203000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-025-02630-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":66,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2630"],"URL":"https:\/\/doi.org\/10.1007\/s00508-025-02630-7","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I.\u00a0Sch\u00fctz-Fuhrmann erhielt Vortrags- und Beratungshonorare von Abbott Diabetes Care, Medtronic, Dexcom, Insulet, B.\u00a0Rami-Merhar hat in den letzten 36\u00a0Monaten Vertragshonorare f\u00fcr Vortr\u00e4ge oder Advisory Boards erhalten: Eli Lilly, Medtronic, Insulet, Abbott, Sanofi, S.E.\u00a0Hofer hat in den letzten 36\u00a0Monaten von folgenden Unternehmen, die auch f\u00f6rdernde Mitglieder der \u00d6DG sind, Forschungsunterst\u00fctzungen und\/oder Honorare erhalten: Eli Lilly, Sanofi und Ypsomed, E.\u00a0Fr\u00f6hlich-Reiterer hat in den letzten 36\u00a0Monaten von folgenden Firmen Honorare\/Forschungsgelder erhalten: Eli Lilly, Medtronic, Novo Nordisk, Roche, M.\u00a0Tauschmann hat in den letzten 36\u00a0Monaten von folgenden Firmen Vortrags- bzw. Beratungshonorare erhalten: Abbott Diabetes Care, Eli Lilly, Medtronic, J.K.\u00a0Mader erhielt Vortragshonorare von AstraZeneca, Abbott Diabetes Care, B\u00f6hringer Ingelheim, Eli Lilly, Medtronic Minimed, Menarini, Merck Sharp & Dohme, Nintamed, Novo Nordisk, Roche Diabetes Care, Sanofi-Aventis, Servier, Wellion, Ypsomed. Advisory Board: Abbott Diabetes Care, B\u00f6hringer Ingelheim, Eli Lilly, Medtronic Minimed, Novo Nordisk, Roche Diabetes Care, Sanofi-Aventis. Gesellschafterin decide Clinical Software GmbH. Forschungsgelder von A. Menarini Diagnostics, B. Braun, Metronom Health, Novo Nordisk, Profusa Inc., Roche Diabetes Care, Sanofi-Aventis., M.\u00a0Resl hat Vortragshonorare und Honorare f\u00fcr Beratungst\u00e4tigkeit von folgenden Firmen erhalten: Boehringer Ingelheim, Sanofi-Aventis, Novo Nordisk, Dexcom, A.\u00a0Kautzky-Willer hat von folgenden Unternehmen, die auch f\u00f6rdernde Mitglieder der \u00d6DG sind, Forschungsunterst\u00fctzungen und\/oder Honorare erhalten: Amgen, Boehringer Ingelheim, El Lilly, Merck Sharp & Dohme, Novartis, Novo Nordisk, Roche, Y.\u00a0Winhofer-St\u00f6ckl hat von folgenden Unternehmen, die auch f\u00f6rdernde Mitglieder der \u00d6DG sind, Forschungsunterst\u00fctzungen und\/oder Honorare erhalten: Abbott, AstraZeneca, Amgen, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Medtronic, Novartis, Novo Nordisk, Roche, Sanofi-Aventis, T.\u00a0Wascher hat von folgenden Unternehmen Honorare erhalten: Abbott, Dexcom, Eli Lilly, Novo Nordisk, L.\u00a0Stechemesser hat von folgenden Unternehmen, die auch f\u00f6rdernde Mitglieder der \u00d6DG sind, Forschungsunterst\u00fctzungen und\/oder Honorare erhalten: Abbott, Roche, Medtronic, S.\u00a0Zlamal-Fortunat hat in den letzten 36\u00a0Monaten Honorare f\u00fcr Vortr\u00e4ge und Advisory Boards von Novo Nordisk, Eli Lilly, AstraZeneca, Boehringer Ingelheim, Medtronic, MSD, Daiichi Sankyo und Novartis erhalten, und R.\u00a0Weitgasser erhielt Vortrags- und Beratungshonorare von Abbott Diabetes Care, Eli Lilly, Medtrust, Novo Nordisk, Roche Diabetes Care, Sanofi. J.\u00a0Harreiter gibt an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}